Patent ID: 8895535

Claim:
A compound of formula I in which R 1 denotes [C(R 4 ) 2 ] n Ar 1 , (CH 2 ) n Het, (CH 2 ) n Cyc, or A, R 2 denotes [C(R 4 ) 2 ] n Ar 2 , CH[B(OH) 2 ]CH 2 Het, (CH 2 ) n Het, (CH 2 ) n Cyc, CH(C≡CH)phenyl or A, R 3 denotes OH, Hal, NH 2 , CN, CF 3 , CHF 2 or N 3 , R 4 denotes H or alkyl having 1, 2, 3 or 4 C atoms, or R 2 and R 4 together denote alkylene having 2, 3, 4 or 5 C atoms, where one CH 2 group is optionally replaced by NH, NA, N—COA, N—(CH 2 ) n Ar 3 , N—(CH 2 ) n Het 2 , CH-A, CH—O—(CH 2 ) n Ar 3 , N—SO 2 A or O and/or is optionally substituted by A, Ar 1 denotes phenyl, naphthyl or biphenyl, each of which is unsubstituted or mono-, di-, tri-, tetra- or pentasubstituted by Hal, A, OH, OA, NH 2 , NHA, NA 2 , NO 2 , CN, COOH, COOA, CONH 2 , CONHA, CONA 2 , NHCOA, NHSO 2 A, COA, CHO, Het 1 , SO 2 NH 2 and/or SO 2 A, Ar 2 denotes phenyl, naphthyl or biphenyl, each of which is unsubstituted or mono-, di-, tri-, tetra- or pentasubstituted by Hal, A, OH, OA, NH 2 , NHA, NA 2 , NO 2 , CN, COOH, COOA, CONH 2 , CONHA, CONA 2 , NHCOA, NHSO 2 A, COA, CHO, Het 1 , SO 2 NH 2 and/or SO 2 A, Ar 3 denotes phenyl, which is unsubstituted or mono-, di- or trisubstituted by Hal, OH, OA and/or A, Het denotes a mono- or bicyclic saturated, unsaturated or aromatic heterocycle having 1 to 4 N, and/or O and/or S atoms which is unsubstituted or mono-, di- or trisubstituted by Hal, A, OH, OA, NH 2 , NHA, NA 2 , NO 2 , CN, COOH, COOA, (CH 2 ) n CONH 2 , (CH 2 ) n CONHA, (CH 2 ) n CONA 2 , NHCOA, NHSO 2 A, COA, CHO, Het 1 , SO 2 NH 2 , SO 2 A and/or ═O, Het 1 denotes a monocyclic saturated, unsaturated or aromatic heterocycle having 1 to 4 N, and/or O and/or S atoms which is unsubstituted or mono-, di- or trisubstituted by Hal, A, OH, OA, NH 2 , NHA, NA 2 , NO 2 , CN, COOH and/or COOA, Het 2 denotes pyridyl, pyrimidinyl, furyl, thienyl, imidazolyl, pyrrolyl, oxazolyl, oxadiazolyl, isoxazolyl, thiazolyl, triazolyl, tetrazolyl or thiadiazole, A denotes unbranched or branched alkyl having 1-10 C atoms, in which 1-7 H atoms are optionally replaced by F, Cl, Br, OH, CHO, COA, COOA, CN, CONA 2 , CONHA and/or CONH 2 , and/or in which one or two non-adjacent CH and/or CH 2 groups are optionally replaced by O, N and/or NR 4 , or Cyc, Cyc denotes cyclic alkyl having 3-7 C atoms, Hal denotes F, Cl, Br or I, n denotes 0, 1, 2, 3 or 4, or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof.